VR Logo

Bharat Immunologicals & Biologicals Corpn. Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1989

Chairman: G Padmanabhan

Managing Director: Chandra Prakash Goyal

Group: PSU

Listing: BSE: 524663

Headquarters: Bulandshahar, Uttar Pradesh

Website: http://bibcol.in

Key Facts

Market cap: R 72.76 Cr

Revenue (TTM): R 114.19 Cr

Earnings (TTM): R -13.71 Cr

Cash: R 7.93 Cr

Total Debt: R 32.22 Cr

Promoters' ownership: 59.25%

Liquidity: Moderate

52 Week range: R 5.41 - 20.80

Face value: R10.00

Shares outstanding: 4,31,80,000

10 Years Aggregate:

  • CFO: -29.87 Cr
  • EBITDA: 14.01 Cr
  • Net Profit: 2.81 Cr

Stock Performance

Time Period Bharat Imm. & Biologicals Corp S&P BSE Healthcare S&P BSE Small Cap
YTD128.3217.93-15.54
1 month9.493.294.22
3 months132.4113.75-15.99
1 Year87.2217.97-22.54
3 Years-16.334.50-8.90
5 Years-7.73-0.111.33
10 Years-0.6611.122.98
As on 03-Jun-2020
Year Bharat Imm. & Biologicals Corp S&P BSE Small Cap S&P BSE Healthcare
2019-38.50-6.85-3.55
2018-65.37-23.41-5.89
201767.6459.640.49
2016-34.241.77-12.88
2015-14.866.7615.06
2014233.5069.2447.43
2013-24.98-11.2322.55